This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bohling, T. Articles by Haltia, M. Search for Related Content PubMed PubMed Citation Articles by Bohling, T. Articles by Haltia, M.

American Journal of Pathology, Vol 148, 367-373, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Ezrin expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumors

T Bohling, O Turunen, J Jaaskelainen, O Carpen, M Sainio, T Wahlstrom, A Vaheri and M Haltia
Department of Pathology, University of Helsinki, Finland.

Ezrin is a cytoskeleton-associated protein that appears to link actin filaments to the plasma membrane. Immunocytochemical studies suggest that ezrin is expressed in epithelial cells but not in mesenchymal cells. In addition, ezrin is expressed by certain epithelial tumors, such as renal cell adenocarcinomas. Ezrin serves as a tyrosine kinase substrate, and is phosphorylated in epidermal growth factor-stimulated cells. Ezrin may thus mediate regulatory signals in different cell functions. We studied the distribution of ezrin in 104 cases of primary tumors of the central nervous system (CNS) by immunocytochemistry. Special interest was focused on capillary hemangioblastoma, owing to its resemblance to renal cell adenocarcinoma, and on malignant gliomas, owing to their frequent epidermal growth factor receptor amplification. The stromal cells of hemangioblastomas were found to be strongly positive for ezrin. No expression was detected in gliomas and, except for hemangioblastomas, ezrin expression was restricted to those few CNS tumors that show epithelial differentiation, ie, choroid plexus papillomas, craniopharyngiomas, ependymomas, and cysts. The diffuse cytoplasmic expression of ezrin in the stromal cells of capillary hemangioblastoma may indicate that stromal cells overexpress ezrin or express ezrin with deficient binding properties.

This article has been cited by other articles:

				T.-S. Yeh, J.-H. Tseng, N.-J. Liu, T.-C. Chen, Y.-Y. Jan, and M.-F. Chen Significance of Cellular Distribution of Ezrin in Pancreatic Cystic Neoplasms and Ductal Adenocarcinoma Arch Surg, December 1, 2005; 140(12): 1184 - 1190. [Abstract] [Full Text] [PDF]

				K. Alfthan, L. Heiska, M. Gronholm, G. H. Renkema, and O. Carpen Cyclic AMP-dependent Protein Kinase Phosphorylates Merlin at Serine 518 Independently of p21-activated Kinase and Promotes Merlin-Ezrin Heterodimerization J. Biol. Chem., April 30, 2004; 279(18): 18559 - 18566. [Abstract] [Full Text] [PDF]

				H. Kobayashi, J. Sagara, H. Kurita, M. Morifuji, M. Ohishi, K. Kurashina, and S.'i. Taniguchi Clinical Significance of Cellular Distribution of Moesin in Patients with Oral Squamous Cell Carcinoma Clin. Cancer Res., January 15, 2004; 10(2): 572 - 580. [Abstract] [Full Text] [PDF]

				M. Gronholm, L. Vossebein, C. R. Carlson, J. Kuja-Panula, T. Teesalu, K. Alfthan, A. Vaheri, H. Rauvala, F. W. Herberg, K. Tasken, et al. Merlin Links to the cAMP Neuronal Signaling Pathway by Anchoring the RI{beta} Subunit of Protein Kinase A J. Biol. Chem., October 17, 2003; 278(42): 41167 - 41172. [Abstract] [Full Text] [PDF]

				T. Makitie, O. Carpen, A. Vaheri, and T. Kivela Ezrin as a Prognostic Indicator and Its Relationship to Tumor Characteristics in Uveal Malignant Melanoma Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2442 - 2449. [Abstract] [Full Text] [PDF]

				O.-M. Mykkanen, M. Gronholm, M. Ronty, M. Lalowski, P. Salmikangas, H. Suila, and O. Carpen Characterization of Human Palladin, a Microfilament-associated Protein Mol. Biol. Cell, October 1, 2001; 12(10): 3060 - 3073. [Abstract] [Full Text] [PDF]

				K. D. Geiger, P. Stoldt, W. Schlote, and A. Derouiche Ezrin Immunoreactivity Is Associated with Increasing Malignancy of Astrocytic Tumors but Is Absent in Oligodendrogliomas Am. J. Pathol., December 1, 2000; 157(6): 1785 - 1793. [Abstract] [Full Text] [PDF]

				F. Scholl, C Gamallo, S Vilar?o, and M Quintanilla Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes J. Cell Sci., January 12, 1999; 112(24): 4601 - 4613. [Abstract] [PDF]

				M Gronholm, M Sainio, F Zhao, L Heiska, A Vaheri, and O Carpen Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin J. Cell Sci., January 3, 1999; 112(6): 895 - 904. [Abstract] [PDF]

				L. Heiska, K. Alfthan, M. Gronholm, P. Vilja, A. Vaheri, and O. Carpen Association of Ezrin with Intercellular Adhesion Molecule-1 and -2 (ICAM-1 and ICAM-2). REGULATION BY PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE J. Biol. Chem., August 21, 1998; 273(34): 21893 - 21900. [Abstract] [Full Text] [PDF]

				M Sainio, F Zhao, L Heiska, O Turunen, M den Bakker, E Zwarthoff, M Lutchman, G. Rouleau, J Jaaskelainen, A Vaheri, et al. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton J. Cell Sci., January 9, 1997; 110(18): 2249 - 2260. [Abstract] [PDF]